"Innovations" (Developments to Watch, Mar. 24) incorrectly described a study on hearing that could begin next year. The study will examine a method for protecting inner-ear hair cells from damage due to a cancer drug.
Before it's here, it's on the Bloomberg Terminal. LEARN MORE